|
Urologix, Inc. - Company Profile Snapshot
| Company Profile: |
Urologix, Inc. |
| Ticker: |
ULGX |
| Exchanges: |
NAS |
| 2009 Sales: |
12,816,000 |
| Major Industry: |
Drugs, Cosmetics & Health Care |
| Sub Industry: |
Medical, Surgical & Dental Suppliers |
| Country: |
UNITED STATES |
| Employees: |
90 |
Business Description
Urologix, Inc.. The Company's principal activity is to develop, manufacture and market non-surgical, catheter-based therapies for the treatment of benign prostatic hyperplasia. The Group market its control units under the CoolWave(R) and Targis(R) names and its procedure kits under the CTC AdvanceTM, CTCTM, Targis, and ProstaprobeTM names. It uses a proprietary cooled microwave technology for the treatment of benign prostatic hyperplasia disease. The Cooled ThermoTherapy can be performed without anesthesia or intravenous sedation and it can be performed in a physician's office or an outpatient clinic. The therapy provides a safe solution that is superior to medication without the complications and side effects inherent in surgical procedures. It manufacture the Targis control unit, CoolWave control unit, and single-use treatment catheters. The Company operates in the United States, Europe, Canada, Asia and other countries.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
